The pharmaceutical sector is experiencing a significant shift in diabetes treatment with the introduction of GLP-1 patches. These revolutionary vehicles offer a likely simple alternative to needle injections for individuals living with type 2 diabetes. By circumventing the requirement for frequent pokes, GLP-1 skin devices promise to boost patient